Fundz

DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer

PRIVATEJun 29, 2026

Position

Chief Financial Officer

Company

Johnson & Johnson DePuy Synthes orthopaedic equipment division

Christina Zamarro
MassachusettsBiotechnologyHealth CareMedicalMedical Device

Description

DePuy Synthes announced the appointment of Christina Zamarro as Chief Financial Officer, effective July 13, 2026. Zamarro has over 25 years of financial leadership experience and joins from the Goodyear Tire & Rubber Company.

Quick answer

DePuy Synthes Appoints Christina Zamarro as Chief Financial Officer (June 29, 2026). Johnson & Johnson DePuy Synthes orthopaedic equipment division is based in Massachusetts, United States.

Who is the new Chief Financial Officer at Johnson & Johnson DePuy Synthes orthopaedic equipment division?
Johnson & Johnson DePuy Synthes orthopaedic equipment division named Christina Zamarro Chief Financial Officer, announced June 29, 2026.
What did Johnson & Johnson DePuy Synthes orthopaedic equipment division announce on June 29, 2026?
DePuy Synthes announced the appointment of Christina Zamarro as Chief Financial Officer, effective July 13, 2026. Zamarro has over 25 years of financial leadership experience and joins from the Goodyear Tire & Rubber Company.
What does Johnson & Johnson DePuy Synthes orthopaedic equipment division do?
The DePuy Synthes orthopaedic equipment division is the orthopaedic business of Johnson & Johnson, covering knee and hip implants.
Where is Johnson & Johnson DePuy Synthes orthopaedic equipment division based?
Johnson & Johnson DePuy Synthes orthopaedic equipment division is based in Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Pixee Medical (June 29, 2026), Inogen (July 1, 2026), Allyntra (July 9, 2026) and CONMED Corporation (June 17, 2026) also announced leadership changes within 45 days of Johnson & Johnson DePuy Synthes orthopaedic equipment division.

Source: Fundz verified event record.

Other recent leadership changes in Medical and Medical Device

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Johnson & Johnson DePuy Synthes orthopaedic equipment division, and when

A new leader at Johnson & Johnson DePuy Synthes orthopaedic equipment division brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Johnson & Johnson DePuy Synthes orthopaedic equipment division raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Johnson & Johnson DePuy Synthes orthopaedic equipment division, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Johnson & Johnson DePuy Synthes orthopaedic equipment division. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Johnson & Johnson DePuy Synthes orthopaedic equipment division

Location

Massachusetts, United States

About

The DePuy Synthes orthopaedic equipment division is the orthopaedic business of Johnson & Johnson, covering knee and hip implants. It was the subject of the proposed merger with Smith & Nephew. The proposed valuation of the division is a maximum of $22 billion.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Johnson & Johnson DePuy Synthes orthopaedic equipment division changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Tim
Senior decision-maker at this company
••••••••@••••••••

See Tim's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Johnson & Johnson DePuy Synthes orthopaedic equipment division's next move

Learn about Strategic plan

Johnson & Johnson DePuy Synthes orthopaedic equipment division changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.